Company Overview
- Headquarters
- 10975 North Torrey Pines Road, San Diego CA
- Website
- ambrx.com
- Phone
- (858) 875-2400
- Employees
- 90
- Founded in
- 2003
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Ambrx
Ambrx is a clinical stage biopharmaceutical company based in San Diego, California. The company employs 90 people and generates approximately $50 million in annual revenue. Ambrx (Nasdaq: AMAM) specializes in developing innovative therapies to manipulate the immune system, particularly in the field of cancer treatment. Their core technology focuses on an expanded genetic code platform, which allows them to create next-generation antibody drug conjugates (ADCs) and other engineered therapies. Ambrx's pipeline includes promising ADC candidates such as ARX517, targeting the prostate-specific membrane antigen (PSMA), and ARX788, targeting HER2. These ADCs are designed to achieve a balance between efficacy and safety in various cancer indications. Ambrx's origins trace back to 2003, when the company was spun out of The Scripps Research Institute. This rich foundation in scientific research informs Ambrx's ongoing development of innovative products that utilize protein engineering technology beyond just ADCs. You can learn more about Ambrx and its innovative therapies by visiting their website at ambrx.com.
Company Leadership
Ambrx Industry Tags
Companies Similar to Ambrx
Analyze industry trends and opportunities by examining competitors and companies comparable to Ambrx, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
50M | Cambridge, MA | |||
50M | 59 | Foster City, CA | ||
50M | 74 | San Diego, CA | ||
50M | 181 | New Haven, CT | 2017 | |
50M | 58 | Carlsbad, CA |